COST-EFFECTIVENESS ANALYSIS OF BIOLOGIC AGENTS IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS: A SYSTEMATIC LITERATURE REVIEW

被引：0
|
作者：
Sokolova, V [1 ]
Tolkacheva, D. [1 ]
机构：
[1] BIOCAD, St Petersburg, Russia
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.1834
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY9
引用
收藏
页码：S375 / S376
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of treatment for moderate-to-severe psoriasis
    Hankin, CS
    Feldman, SR
    Pearce, D
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 654 - 654
  • [2] Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment
    Wu, Jashin J.
    Rastogi, Shipra
    Menges, Brandy
    Lingohr-Smith, Melissa
    Lin, Jay
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB83 - AB83
  • [3] COST-EFFECTIVENESS OF SEQUENCES OF BIOLOGIC TREATMENTS FOR MODERATE-TO-SEVERE PSORIASIS IN FINLAND
    Asseburg, C.
    Valgardsson, S.
    Soini, E. J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A507 - A508
  • [4] A COST-EFFECTIVENESS ANALYSIS OF COMMONLY USED BIOLOGIC DRUGS FOR THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE UNITED STATES
    Wu, J. J.
    Feldman, S. R.
    Rastogi, S.
    Menges, B.
    Lingohr-Smith, M.
    Lin, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S240 - S240
  • [5] The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis
    Rouse, Nicole C.
    Farhangian, Michael E.
    Wehausen, Brooke
    Feldman, Steven R.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (06) : 877 - 884
  • [6] Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States
    Wu, Jashin J.
    Feldman, Steven R.
    Rastogi, Shipra
    Menges, Brandy
    Lingohr-Smith, Melissa
    Lin, Jay
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (08) : 769 - 774
  • [7] A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis
    Yifan Hu
    Zeyu Chen
    Yu Gong
    Yuling Shi
    [J]. Clinical Drug Investigation, 2018, 38 : 191 - 199
  • [8] A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis
    Hu, Yifan
    Chen, Zeyu
    Gong, Yu
    Shi, Yuling
    [J]. CLINICAL DRUG INVESTIGATION, 2018, 38 (03) : 191 - 199
  • [9] Cost-effectiveness analysis of amevivetm (Alefacept) in the treatment of patients with moderate-to-severe psoriasis
    Iskedjian, M
    Barkovsky, L
    Desjardins, O
    Walker, JH
    Dorkalam, M
    Shear, N
    Einarson, TR
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 330 - 330
  • [10] COST-EFFECTIVENESS OF BIOLOGIC THERAPIES FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GERMANY
    Betts, K.
    Yan, Y.
    Sundaram, M.
    Hengst, N.
    Wolff, M.
    Bensimon, A. G.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A570 - A570
12345